Annexon Biosciences
Developing complement medicines
Neurodegeneration
Autoimmune
Ophthalmology
About Annexon Biosciences
Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company focused on developing complement medicines for autoimmune, neurodegenerative, and ophthalmic disorders. The company’s innovative pipeline includes ANX005, ANX007, and ANX009, targeting the classical complement pathway. Annexon employs a biomarker-driven strategy to enhance the success of its portfolio.
Find Remote Jobs
Connect with top companies hiring for remote jobs, work-from-home roles, and 100% online jobs worldwide.
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.